Sodium Glycerophosphate Market

Sodium Glycerophosphate Market Size, Share & Industry Analysis, By Source:- Synthetic, Recombinant DNA technology, By End-User:-Hospitals, Retail Pharmacies, Online Pharmacies, and Forecast Period 2025-2035

The Sodium Glycerophosphate market is projected to grow at a CAGR of 5.6% from 2025 to 2035, driven by increasing demand for parenteral nutrition products, rising prevalence of malnutrition and critical illnesses, and expanding applications in the pharmaceutical and food industries. Sodium Glycerophosphate is a sodium salt of glycerophosphoric acid that serves as a vital source of phosphorus and energy in intravenous nutrition formulations. It supports bone health, cellular metabolism, and acts as a buffer to maintain acid-base balance in clinical nutrition.

Sodium Glycerophosphate is extensively used in total parenteral nutrition (TPN) solutions to provide essential electrolytes and minerals to patients who cannot consume food orally or enterally. It is also incorporated in some pharmaceutical formulations for electrolyte replenishment and is used as a food additive to enhance nutritional content. Its high solubility, biocompatibility, and safety profile make it indispensable in critical care settings, neonatal nutrition, and recovery therapies.

North America leads the Sodium Glycerophosphate market owing to advanced healthcare infrastructure, increasing geriatric population, and rising awareness of malnutrition management in hospitals. Europe follows with steady growth due to established parenteral nutrition programs and regulatory support. The Asia-Pacific region is expected to register the fastest CAGR, fueled by expanding hospital networks, growing incidences of chronic diseases, and improving access to advanced nutritional therapies in China, India, and Japan. Latin America and the Middle East & Africa show gradual growth supported by healthcare development and rising demand for critical care nutrition.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Sodium Glycerophosphate
  • Key End-Users & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
  • Synthetic
  • Recombinant DNA technology
  • Key End-Use Industries
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
  • Paul Lohmann GmbH & Co. KGaA – Germany
  • Global Calcium – India
  • Hebei Weibang Biotechnology Co., Ltd. – China
  • Hebei Mojin Biotechnology Co., Ltd. – China
  • Shaanxi TNJONE Pharmaceutical Co., Ltd. – China
  • Conier Chem and Pharma Limited – China
  • PT Chem Group Limited – China
  • AK Scientific, Inc. – USA
  • American Custom Chemicals Corporation – USA
  • Xiamen Hisunny Chemical Co., Ltd. – China
  • Jinan Great Chemical Co., Ltd. – China
  • Jai Radhe Sales – India
  • Alpha Chemika – India
  • Shreeji Pharma International – India
  • Uma Brothers – India
  • Jiangsu Clent Chemical Co., Ltd. – China
  • Conier Chem and Pharma Limited – China
  • PT Chem Group Limited – China
  • AK Scientific, Inc. – USA
  • American Custom Chemicals Corporation – USA
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Sodium Glycerophosphate?
Sodium Glycerophosphate is a phosphate ester used primarily as a mineral supplement to provide phosphorus and sodium in parenteral nutrition formulations. It supports bone metabolism, energy production, and cellular function, making it essential in treating or preventing phosphorus deficiency in patients who cannot consume sufficient nutrition orally. It is commonly included in intravenous (IV) nutrition solutions and some pharmaceutical products.
What is the market growth of Sodium Glycerophosphate?
The global Sodium Glycerophosphate market is projected to grow at a CAGR of 5.6% from 2025 to 2035, increasing from approximately USD 120 million in 2025 to around USD 215 million by 2035. Growth is driven by the rising prevalence of malnutrition, increasing use of parenteral nutrition in hospitals, and growing awareness of the importance of balanced electrolyte supplementation.
What are the drivers of the Sodium Glycerophosphate market?
Key drivers include increasing demand for parenteral and enteral nutrition in patients with gastrointestinal disorders, surgeries, or critical illnesses, the aging population with higher nutritional support needs, and advancements in hospital care infrastructure. The growing prevalence of chronic diseases and trauma cases that require intravenous nutrition further supports market expansion.
Who are the key players operating in the Sodium Glycerophosphate market?
Leading players in the Sodium Glycerophosphate market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Hospira (Pfizer), and Grifols, S.A. These companies manufacture sterile injectable nutrition products containing Sodium Glycerophosphate for clinical use.
Which region will exhibit the fastest growth in the Sodium Glycerophosphate market?
The Asia-Pacific region is expected to show the fastest growth due to increasing healthcare investments, rising hospital admissions requiring nutritional support, and expanding critical care facilities in countries such as China, India, and Japan. North America and Europe remain mature markets with steady demand driven by established parenteral nutrition practices.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.